Capital World Investors 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-13 11:44 am Sale | 2025-03-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Capital World Investors | 3,177,587 6.400% | -196,477 (-5.82%) | Filing |
| 2024-11-13 12:54 pm Purchase | 2024-11-07 | 13G | KalVista Pharmaceuticals, Inc. KALV | Capital World Investors | 3,374,064 7.800% | 3,374,064 (New Position) | Filing |